Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by ANALIAS00on Nov 14, 2020 12:19pm
127 Views
Post# 31901326

RE:RE:RE:RE:RE:RE:More insider buying: Littlejohn, Gary Peter almost 8k shares

RE:RE:RE:RE:RE:RE:More insider buying: Littlejohn, Gary Peter almost 8k sharesCorrect...first purchase .... I am happy and was happy for all good news so far. But as all of other shareholders, cant wait for a momentum that can lead the sharprice up. But be honnest ... If henwas eecpecting a lot of success mid term .... Hisnpurchase could have been more important. I did not say it was a bad news....just saying that his 24k is not a big investment for him. Not a big signal to me. Still a positive one but...
SPCEO1 wrote: My mistake - Trudeau was the earlier buyer - I think this was Molson's first purchase.

SPCEO1 wrote: So you woke up on the wrong side of bed today? Look, any insider buying is good. There is no bad insider buying - none. There are only degrees of good insider buying - good, really good and amazingly good - but it is all good so it should be of at least some encouragement to you. I also would point out that he has apparently bought on two seaparate occaisions this past week - are you aware that there will not be a third occaision? 

On the timing of the protocol submission, they are about a month behind what they originally indicated but there were extenuating circumstances that led to the delay, notably the desire to improve the submission based off what was learned by the failure of others. Maybe they should have done that previously but the ICPT CRL was brand new and experts like Stephen Harrison and Loomba probably needed some time to review what they could about that. So, the delay was short and sensible. I don't like delays but they are commonplace in drug development and, given the odd situation this protocol comes to the FDA, I am all for optimizing it to the maximum to remove any questions other than the obvious one of minimal data from phase II. 

So cheer up! Insiders are buying and the NASH protocol will likely be filed next week. And if you were not cheered up by that $2.75 billion cancer deal last week for a company that looks a lot like TH's cancer drug, than maybe you should seek some professional counseling! 

ANALIAS00 wrote: This is not a bad news for sure. I will not complain but my comment or my question is what does represent this investment for this person ? 500$ for me ? If he realy was expecting a positive impact on the SP mid term, even just a little 25%, he would have bougth a lot more. This sound like a standard and minimum investment required when joining a new board. A polite gesture. Are they finally be annoncing that filling was completed ? Mid november already....again they keep missing their own agenda.
Thao977 wrote: Yesterday, Molson bought 24k. 3625976 2020-10-16 2020-11-13 Proprit directe : 00 - Solde d'ouverture-Dclaration initiale en format SEDI 3625977 2020-11-12 2020-11-13 Proprit directe : 10 - Acquisition ou alination effectue sur le march +19,200 2.9300 19,200 3625978 2020-11-12 2020-11-13 Proprit directe : 10 - Acquisition ou alination effectue sur le march +400 2.8800 19,600 3625979 2020-11-12 2020-11-13 Proprit directe : 10 - Acquisition ou alination effectue sur le march +2,100 2.9200 21,700 3625980 2020-11-12 2020-11-13 Proprit directe : 10 - Acquisition ou alination effectue sur le march +2,000 2.9000 23,700 3625981 2020-11-12 2020-11-13 Proprit directe : 10 - Acquisition ou alination effectue sur le march +300 2.9500 24,000

 






Bullboard Posts